Analysis of Multiple Vitamins Serum Levels and Disease-Related Factors in Children with Acute Leukemia
Table 8
Multivariate analysis of factors influencing different treatment regimens in children with acute leukemia.
Regimen (others = 0)
B
Wald X2
Exp (B)
95% of Exp (B) confidence interval
Lower limit
Upper limit
CAML
Intercept
0.548
0
1
Platelet count (PLT)
0.01
4.682
1.01
1.001
1.019
0.030
Neutrophils (N)
−0.801
4.969
0.449
0.222
0.908
0.026
Activated partial thromboplastin time (APTT)
0.022
0.148
1.022
0.915
1.141
0.701
Vitamin B6 (VB6)
−0.013
0.177
0.987
0.927
1.05
0.674
Vitamin B12 (VB12)
−0.003
0.471
0.997
0.987
1.006
0.492
Immunophenotype = 0.00a
0.165
0
1.18E + 00
0
1.00E + 00
Immunophenotype = 1.00b
−17.98
0
1.55E − 08
0
9.99E − 01
Diagnosis = 0c
−17.335
0
2.96E − 08
0
0.999
MTX
Intercept
19.84
20.885
0
Platelet count (PLT)
0.002
0.369
1.002
0.995
1.01
0.543
Neutrophils (N)
0.005
0.002
1.005
0.799
1.264
0.968
Activated partial thromboplastin time (APTT)
−0.078
0.86
0.925
0.784
1.091
0.354
Vitamin B6 (VB6)
−0.016
0.23
0.984
0.921
1.052
0.632
Vitamin B12 (VB12)
−0.005
0.849
0.995
0.984
1.006
0.357
Immunophenotype = 0.00a
−16.297
177.051
8.37E − 08
7.59E − 09
9.23E − 07
<0.001
Immunophenotype = 1.00b
−15.147
125.811
2.64E − 07
1.87E − 08
3.73E − 06
<0.001
Diagnosis = 0c
−17.91
.
1.67E − 08
1.67E − 08
1.67E − 08
.
VDLP
Intercept
10.317
0
0.999
Platelet count (PLT)
0.001
0.143
1.001
0.994
1.008
0.705
Neutrophils (N)
−0.499
5.798
0.607
0.405
0.911
0.016
Activated partial thromboplastin time (APTT)
−0.412
10.908
0.662
0.518
0.846
0.001
VB6
0.065
4.721
1.067
1.006
1.131
0.030
VB12
0.007
2.348
1.007
0.998
1.016
0.125
Immunophenotype = 0.00a
−2.274
0
0.103
0
.b
1
Immunophenotype = 1.00b
−3.488
0
0.031
0
.b
1
Diagnosis = 0c
−20.163
0
1.75E − 09
0
.b
0.998
.aAML was considered as the control group of immunophenotype, B cell type: immunophenotype = 0.00; bT cell type: immunophenotype = 1.00; cALL acted as the control group of diagnostic results, AML: diagnosis = 0. CAML, cyclophosphamide + cytosine arabinoside+6-mercaptopurine + pegaspargase; MTX, methotrexate group; VDLP, vindesine + daunomycin + L-asparaginasum + prednisone.
